Find Academic Supervisors

Mark Liberman is a Trustee Professor at the University of Pennsylvania , holding appointments in the Department of Linguistics and Department of Computer and Information Science . He serves as Director of the Linguistic Data Consortium and Faculty Director of Ware College House . His career spans linguistics, speech technology, and computational methods. Education: Harvard University (1965-1969), MIT (M.S. 1972, Ph.D. 1975) Professional Experience: AT&T Bell Laboratories (1975-1990), University of Pennsylvania (1990-present) His research interests include: Corpus-based Phonetics : Analyzing speech patterns via large-scale datasets. Clinical Applications : Developing speech biomarkers for neurodegenerative diseases. Tonal Phonology : Studying lexical tone and intonation in languages like Yoruba and Mandarin. Formal Annotation Models : Creating frameworks for linguistic data standardization. Recent publications highlight automated speech analysis, cross-linguistic prosody, and digital biomarkers for conditions like ALS-FTD and Alzheimer’s. His collaborations span computational linguistics , neurology , and cognitive science . Scientific awards include the IEEE James L. Flanagan Award (2017), Antonio Zampolli Prize (2010), and fellowships from the AAAS and Linguistic Society of America . He advises PhD students May Chan and Jonathan Him Nok Lee and contributes to editorial boards for journals like Cognition and Annual Review of Linguistics . His work bridges speech science , language technology , and neurocognitive research .

• Corpus-based Phonetics
• Speech and Language Technology
• Clinical Applications of Linguistics
• +6 more

Dr. Camila Aquino serves as Assistant Professor in both the Department of Clinical Neurosciences and Department of Community Health Sciences at the University of Calgary's Cumming School of Medicine, and is a Full Member of the Hotchkiss Brain Institute. As Medical Director of the Deep Brain Stimulation Program, she specializes in Parkinson's disease, essential tremor, dystonia, and chorea management, including EMG-guided botulinum toxin injections. Her educational background includes: M.D. in Medicine from Escola Superior de Ciencias da Santa Casa (2005) M.S. in Neurosciences from Federal University of Sao Paulo (2012) Ph.D. in Neurosciences from Federal University of Sao Paulo (2019) M.S. in Health Research Methods, Clinical Epidemiology from McMaster University (2020) Dr. Aquino's research addresses unmet needs in movement disorders through innovative clinical trial designs for Parkinson's disease, focusing on precision-medicine approaches, early intervention, and outcome optimization. She actively evaluates neuromodulation therapies including Deep Brain Stimulation, Spinal Cord Stimulation, and MRgFUS, with emphasis on expanding indications and improving patient outcomes. As an International Parkinson and Movement Disorder Society member, she chairs the web-based learning committee and serves on evidence-based medicine and outcome measure committees. Analysis of her 15 most recent publications (2021-2025) reveals a cohesive research trajectory centered on Parkinson's disease management, with dominant themes in motor fluctuation treatments, deep brain stimulation methodology, and clinical trial innovation. Her work bridges fundamental clinical practice guidelines with advanced neuromodulation technologies, demonstrating consistent commitment to evidence-based solutions for movement disorders. Her scientific recognition includes: Parkinson Canada research grant Mohammed Al Zaibak Foundation scholarship CAPES scholarship from Brazilian Ministry of Education Dr. Aquino has secured significant research funding supporting clinical trials in Parkinson's disease neuroprotection and neuromodulation therapies. While specific student advisees aren't listed, her leadership of the DBS Program and active clinical trial portfolio indicate substantial mentorship responsibilities. Her grant portfolio emphasizes translational research with direct clinical impact. She directs the University of Calgary's Deep Brain Stimulation Program and contributes to the MRI-guided focused ultrasound initiative. Through her International Parkinson and Movement Disorder Society committee roles, she shapes global educational standards and evidence-based practices in movement disorders.

• Movement Disorders
• Parkinson's Disease
• Deep Brain Stimulation
• +5 more

Alexis Battle is an Associate Professor at Johns Hopkins University with appointments in Biomedical Engineering , Computer Science , and Genetic Medicine (secondary). She directs the Malone Center for Engineering in Healthcare and serves as Deputy Director of the Data Science and AI Institute . Educated at Stanford University (PhD in Computer Science, 2013), Battle transitioned to academia after leadership roles at Google. Research Focus: Battle’s work bridges genomics and machine learning , emphasizing the impact of genetic variation on human health. Her lab develops tools like Watershed to predict functional effects of rare variants, aiming to enhance rare disease diagnosis. Key themes include non-coding DNA analysis , personalized genomics , and systems biology , with applications in cardiovascular disease and neurodegenerative disorders . Publications & Awards: Over 60 peer-reviewed articles in journals like Nature , Science , and Genome Biology , with recent emphasis on single-cell transcriptomics , multiomics integration , and telomere biology . Recipient of the President’s Frontier Award (2022), Microsoft Investigator Fellowship (2019), and Searle Scholar (2016). Scientific Awards: 2022 President’s Frontier Award 2019 Microsoft Investigator Fellowship 2019 Johns Hopkins Discovery Award 2017 Johns Hopkins Catalyst Award 2016 Searle Scholar Advising & Funding: Mentors 11 PhD students, 3 undergraduates, and postdoctoral fellows. Her research is funded by NIH, Searle Scholars, and institutional grants. The Battle Lab collaborates on projects like the GTEx Consortium , focusing on gene regulation and clinical genomics .

• Genomics
• Machine Learning
• Computational Biology
• +3 more

Johannes Larsch is a tenure-track Assistant Professor at the Center for Integrative Genomics within the Faculty of Biology and Medicine at Université de Lausanne (UNIL). His research focuses on understanding the neuronal mechanisms underlying social interactions, using larval zebrafish as a model organism. He employs advanced techniques like virtual reality and optical imaging to study how social signals are processed in the brain. Education: Bachelor of Biology, University of Konstanz, Germany PhD in Neurobiology, Rockefeller University, USA (lab of Cori Bargmann) Postdoc at Max Planck Institute of Neurobiology, Germany (with Herwig Baier) Research interests center on neuronal circuits driving group behavior, social recognition, and the interplay between genetics and environment in shaping behavior. His lab investigates how individual brains coordinate collective social behaviors through studies of neuronal activity and circuit dynamics. Current lab openings include fully funded PhD and PostDoc positions focused on social neuroscience and neurogenomics. Contact: johannes.larsch@unil.ch .

• Neuroscience
• Social Behavior
• Neuronal Circuits
• +3 more

Corrie Moreau is the Martha N. & John C. Moser Professor of Arthropod Biosystematics and Biodiversity at Cornell University, serving as Director & Curator of the Cornell University Insect Collection. She holds affiliations with the Department of Ecology and Evolutionary Biology and the College of Arts and Sciences. Her research focuses on symbiotic factors driving speciation, adaptation, and diversification in insects, particularly ants. Moreau’s work integrates molecular methods, next-generation sequencing, and field-based research to study biodiversity across scales. Education: Ph.D. in Organismic and Evolutionary Biology from Harvard University (2007), M.Sc. in Biology from San Francisco State University/California Academy of Sciences (2003), B.S. in Biology from San Francisco State University (2000). Research Interests: Evolutionary patterns/processes, organismal biology, plant-animal interactions, chemical ecology, sustainability, and microbiome dynamics. Her lab (Moreau Lab) investigates ant-microbe symbioses, host-microbe interactions, and the role of symbioses in macroevolutionary processes. Recent work includes studies on ant phylogenetics, gut microbiome evolution, and the impact of invasive species on native ecosystems. Publications highlight her contributions to understanding ant evolution, microbial symbiosis, and biogeography. Grants include NSF-funded projects on ant genomics and symbiosis. She advocates for natural history collections and their role in biodiversity research and education.

• Evolutionary Patterns and Processes
• Organismal Biology
• Plant-animal Interactions
• +13 more

Professor Victor Fung is a leading academic in neurology and motor control at the Sydney Medical School , University of Sydney. He serves as Director of the Movement Disorders Unit at Westmead Hospital and holds prominent roles in the International Parkinson and Movement Disorder Society (President) and the Asia Pacific Affairs Committee of the Australian and New Zealand Association of Neurologists. His research focuses on Parkinson's disease , dystonia , tremor , and movement disorder genetics , with over 250 peer-reviewed publications and an h-index of 61. His work spans Clinical trials for Parkinson's treatments (e.g., foslevodopa/foscarbidopa infusion, incobotulinumtoxinA) Genetic studies on dystonia and Parkinsonism Neurophysiological assessments of tremor and balance Development of screening tools for dystonia and Parkinson's complications Key article trends highlight genetic diversity in dystonia, neuroinflammatory mechanisms in tremor, and behavioral neurology in Parkinson's disease. He contributes to editorial boards of npj Parkinson's Disease , Journal of Clinical Movement Disorders , and Faculty Opinions . While no explicit student lists are provided, his collaborations span global institutions. His clinical work at Westmead Hospital addresses device-assisted therapies and complex movement disorders.

• Neurology
• Movement Disorders
• Parkinson's Disease
• +6 more

Adam Yala is an Assistant Professor of Computational Precision Health, Statistics, and Electrical Engineering and Computer Science at UC Berkeley and UCSF. He is also the Founder & CEO of Voio Inc., a company focused on clinical translation of AI tools. PhD in Computer Science from MIT (2022) His research lies at the intersection of Machine Learning and Precision Medicine, with a focus on robust AI tools for clinical deployment, personalized screening policies, and private data sharing. Current work includes multi-modal imaging analysis, decision guarantees in clinical workflows, and prospective trials in oncology and radiology. Recent publications highlight advancements in AI for cancer risk prediction, vision-language models in healthcare, and data privacy techniques. Tools like Mirai are implemented in 66 hospitals across 30 countries. Bakar Fellows Spark Award (2024) Eppy Award: Investigative Reporting (2022) Falling Walls Finalist: Life Science (2022) NSF Fellowship (2016) He advises PhD students in AI-driven healthcare and collaborates with hospital systems globally. His lab emphasizes clinical translation of machine learning methods in radiology and oncology.

• Machine Learning
• Artificial Intelligence
• Precision Medicine
• +5 more

Heping Zhang is the Susan Dwight Bliss Professor of Biostatistics at the Yale School of Public Health , with secondary appointments in the Child Study Center , Department of Statistics and Data Science , and Department of Obstetrics, Gynecology, and Reproductive Sciences . He directs the Collaborative Center for Statistics in Science (C²S²) and leads the Reproductive Medicine Network data coordinating center. Education: PhD in Statistics, Stanford University (1991) Postdoctoral Fellow, Mathematical Science Research Institute (1991) Research Focus : Zhang specializes in biostatistical methodology for genomic data analysis , clinical trials , and reproductive medicine . His work bridges genetics , mental health , and maternal-child health through innovative statistical approaches. Awards : 2023 Web of Science Highly Cited Researcher 2023 International Chinese Statistical Association Distinguished Achievement Award 2022 Institute of Mathematical Statistics Neyman Award and Lecture 2011 Royan Institute International Research Award 2011 Institute of Mathematical Statistics Medallion Award 2008 Harvard School of Public Health Myrto Lefokopoulou Distinguished Lecturer Professional Roles : He served as President of the International Chinese Statistical Association (2019) and Former Editor of the Journal of the American Statistical Association - Applications and Case Studies . His lab develops open-source software tools like ABESS , STREE , and modSaRa for genomic and clinical data analysis.

• Biostatistics
• Genetics
• Maternal & Child Health
• +4 more

Professor Guy Williams is a leading academic at the University of Cambridge with a focus on imaging science and clinical neurosciences, affiliated with Downing College and the Wolfson Brain Imaging Centre . Holding a PhD in Physics from his initial Natural Sciences degree, he specializes in nuclear magnetic resonance (NMR) and MRI techniques for brain imaging. Education: BA, PhD in Physics His research centers on non-invasive imaging of brain structure and function, particularly in traumatic brain injury (TBI) and dementia. His work involves developing novel MRI pulse sequences and advanced data analysis algorithms, including AI-based diagnostic tools. He leads studies on white matter integrity post-trauma, longitudinal dementia assessment, and applications of MRI in disorders of consciousness and addiction. Recent publications highlight collaborations in traumatic brain injury outcomes, AI-guided dementia prediction, and neuroimaging of post-COVID cognitive deficits. His team's work on ultra-high field laminar fMRI and distortion correction methods has advanced clinical neuroscience applications. Key techniques include diffusion tensor imaging (DTI), 7 Tesla MRI, and positron emission tomography (PET/MR). His research spans from basic NMR physics to clinical translation, with a strong emphasis on multi-site studies and real-world diagnostic implementation.

• Nuclear Magnetic Resonance (NMR)
• In vivo imaging
• MRI pulse sequence development
• +7 more

Omer Bayraktar is a Group Leader at the Wellcome Sanger Institute , leading research in the Cellular Genomics Programme. His work focuses on decoding human brain cellular diversity using spatial transcriptomics , imaging , and functional screening to study neural complexity in health and disease. Bayraktar's educational background includes a PhD from HHMI under Chris Doe, investigating neural diversity development in Drosophila , followed by postdoctoral work at University of California, San Francisco and University of Cambridge as a Life Sciences Research Foundation Fellow. He developed a spatial transcriptomic pipeline during his postdoc to analyze astrocyte heterogeneity in the cerebral cortex. His research explores neural cell type mapping , glial-neuronal interactions , and cellular pathways in neurodevelopmental disorders . Recent publications emphasize 3D tissue mapping , multi-omic integration , and computational tools like Cell2fate and WebAtlas. His work bridges neurogenetics and computational biology to advance understanding of human tissue ecosystems. Bayraktar's lab collaborates with the Human Cell Atlas initiative and develops technologies such as automated histology pipelines and highly-multiplexed smFISH for molecular cell typing. His team also investigates glia-based therapies and astrocyte functional heterogeneity in neurodevelopmental contexts. Key scientific contributions include: Discovering astrocyte layer patterns independent of neuronal laminae Developing cell2location for spatial cell mapping Characterizing Drosophila neural stem cell models with human relevance Notable awards include the Life Sciences Research Foundation Fellowship during his postdoctoral training. His current group includes a PhD student , Senior Data Scientists , and Bioinformaticians .

• Neural Diversity
• Spatial Transcriptomics
• Glia Biology
• +3 more

Zion Zibly, MD, MBA is an Associate Professor in the Department of Neurosurgery at Yale School of Medicine . He holds multiple leadership roles including Director of the Center of Neuromodulation , Director of the Center of Neurosurgical Cancer Pain , and Head of Stereotactic & Functional Neurosurgery and the Focused Ultrasound Institute . Previously served as Chair of Neurosurgery at Sheba Medical Center after graduating from Technion’s Faculty of Medicine (MD) and Coller School of Management (MBA). Research Interests: Specializes in Neuromodulation for movement disorders (Parkinson’s, tremors, dystonia), Deep Brain Stimulation , Gene Therapy for pediatric neurodegenerative conditions, Oncological Neurosurgery , and Neurological Pain Management . Combines Functional Neurosurgery with Focused Ultrasound technology. Scientific Contributions: Participated in pioneering Alzheimer’s brain stimulator procedures and Gene Therapy applications. Active member of the North American Association of Functional Neurosurgery and Israeli Neurosurgical Society . Clinical Expertise: Implantation of electrostimulators for Parkinson’s and essential tremor, treatment of Benign/Malignant CNS Tumors , and management of Neurological Pain Conditions . Affiliated with Yale Cancer Center and Center for Brain & Mind Health .

• Neurosurgery
• Functional Neurosurgery
• Neuromodulation
• +3 more

Istvan Mody is a Professor at the University of California, Los Angeles (UCLA) with appointments in the Department of Neurology and Department of Physiology . His research focuses on synaptic signaling in health and disease, including mechanisms of GABAergic transmission, calcium homeostasis, and their roles in neurological disorders such as epilepsy, Alzheimer's disease, Huntington's disease, stress, alcoholism, and postpartum depression. He utilizes advanced techniques like patch-clamp electrophysiology, neuroanatomical and immunohistochemical methods, and molecular biology in animal models and human brain tissue . Research Interests: Dr. Mody investigates the physiology, pharmacology, and pathology of synaptic transmission and extrasynaptic receptor activation , with a particular emphasis on GABA(A) receptors and their subunit-specific modulation. His work explores how disruptions in excitation-inhibition balance contribute to neurological diseases, including mechanisms of tonic inhibition , calcium signaling , and neurosteroid interactions . He also studies the effects of chronic stress and hormonal fluctuations on neural excitability and behavior. Publications Trends: Recent studies highlight his work on gamma oscillations in Alzheimer's models, microglial dynamics , and rehabilitation strategies for stroke. His lab develops optical tools like dqGEVI for neuronal activity monitoring and investigates human brain organoids to model network dysfunction in epilepsy and intellectual disability. Laboratory Location: 635 Charles Young Dr S, Los Angeles, CA 90095, United States.

• Neuroscience
• Neurology
• Pharmacology
• +12 more

Professor Richelle Mychasiuk, affiliated with the School of Medical Sciences at the University of Sydney, specializes in Sleep Biology and the neurobiological impacts of early life experiences. Her research focuses on how perinatal trauma and adverse childhood events shape neurodevelopment, increasing susceptibility to sleep disturbances, chronic pain, and post-concussive symptomologies in adolescents, with a particular emphasis on sex differences. Education: PhD in Neuroscience Her work explores mechanisms by which early life stressors "under the skin" to alter neuroplasticity and microbiome-gut-brain interactions. She co-founded The GIN hub, integrating Gastroenterology, Immunology, and Neuroscience to study complex chronic disease models. Recent articles highlight her contributions to understanding dietary influences on pain, epigenetic modifications, microbiome depletion effects, and neurovascular interventions in TBI models. Grants: 2025 FMH Start-up Scheme (Faculty of Medicine and Health, University of Sydney) Collaborations: Brain and Mind Centre, University of Sydney; clinical research partnerships for translational studies.

• Sleep Biology
• Neurodevelopment
• Chronic Pain
• +5 more

Dr. Georgie Agar is a Lecturer at the School of Life & Health Sciences, Aston University , affiliated with the College of Health and Life Sciences and the Applied Health Research Group . Her research focuses on sleep disorders, self-injurious behavior, and caregiver impact in individuals with intellectual disabilities and rare genetic syndromes like Smith-Magenis and Angelman syndromes. Research Interests : Dr. Agar specializes in developing inclusive clinical assessment tools for sleep, pain, and behavior in neurodevelopmental populations. She employs mixed-methods, meta-analytic approaches, and longitudinal studies to explore sleep trajectories, behavioral conditioning models, and caregiver experiences. Publications : Her work spans sleep management in Smith-Magenis syndrome, overactivity metrics in genetic conditions, and systematic reviews on self-restraint in autism. Key journals include Molecular Autism , Orphanet Journal of Rare Diseases , and Research in Developmental Disabilities . Labs & Collaborations : She collaborates with the Aston Institute of Health & Neurodevelopment , focusing on neurodevelopmental research and cross-institutional partnerships in sleep and behavioral science.

• Sleep Disorders
• Intellectual Disability
• Behavioral Psychology
• +5 more

Bertram Müller-Myhsok is a Research Professor and Research Group Leader at the Max Planck Institute of Psychiatry in Munich, Germany. His research focuses on statistical genetics and transcriptomic data analysis in psychiatric disorders, particularly major depression, PTSD, schizophrenia, and their treatment responses. He integrates machine learning with genetic and clinical data to develop predictive models and stratified treatment approaches. Professional activities include leadership roles in the International Max Planck Research School for Translational Psychiatry and collaborations with institutions like the Institut du Cerveau (Paris) and Bernhard Nocht Institute (Hamburg). His work spans genetic epidemiology, psychiatric genomics, and precision medicine, with over 400 publications in high-impact journals. Key research areas include identifying genetic risk factors for mental disorders, developing polygenic scores, and leveraging omics data to uncover disease mechanisms. He leads projects like Psych-STRATA, a Horizon Europe-funded initiative advancing personalized psychiatry through pharmacogenomics.

• Psychiatric Genetics
• Statistical Genetics
• Transcriptomics
• +3 more